<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR197">
 <label>197.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Ceccarelli</surname>
    <given-names>G</given-names>
   </name>
   <name>
    <surname>Alessandri</surname>
    <given-names>F</given-names>
   </name>
   <name>
    <surname>dâ€™Ettorre</surname>
    <given-names>G</given-names>
   </name>
   <name>
    <surname>Borrazzo</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Spagnolello</surname>
    <given-names>O</given-names>
   </name>
   <name>
    <surname>Oliva</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Ruberto</surname>
    <given-names>F</given-names>
   </name>
   <name>
    <surname>Mastroianni</surname>
    <given-names>CM</given-names>
   </name>
   <name>
    <surname>Pugliese</surname>
    <given-names>F</given-names>
   </name>
   <name>
    <surname>Venditti</surname>
    <given-names>M</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Is teicoplanin a complementary treatment option for COVID-19? The question remains</article-title>
  <source>Int J Antimicrob Agents</source>
  <year>2020</year>
  <volume>56</volume>
  <issue>2</issue>
  <fpage>106029</fpage>
  <lpage>106029</lpage>
  <?supplied-pmid 32454071?>
  <pub-id pub-id-type="pmid">32454071</pub-id>
 </element-citation>
</ref>
